OQRO

Weekly recap

Insider trades and Congress trades, week of Apr 6–12, 2026

In the week of Apr 6–12, 2026, insiders filed 75 open-market purchases worth about $12.2M and 431 open-market sales; the largest purchase was $3.22M of Goldman Sachs (GS) by GOLDMAN SACHS GROUP INC; members of Congress disclosed 134 purchases and 69 sales; 10 purchases stood out against the company's record since 2006.

By filing date, Monday to Sunday. Every line links to its SEC, House or Senate record. Public filings, not investment advice.

Purchases that stand out against 20 years of filings

Measured against every open-market trade the company's insiders filed since 2006. See all of them on the rare insider trades page.

Largest insider purchases

Largest insider sales

Congress trades disclosed

Members report a value range, not an exact amount; the trade can be up to 45 days older than its report.

Executives who announced they are leaving

  • The Vita Coco Company (COCO) · Apr 10, 2026

    “John Leahy, a member of the Board of Directors of The Vita Coco Company, Inc. (the “Company”) has decided to retire from the Company's Board of Directors and will not stand for reelection at the Company's 2026 Annual Meeting of Stockholders on June 3, 2026.” 8-K

  • Douglas Emmett (DEI) · Apr 10, 2026

    “On April 6, 2026, Leslie E. Bider informed Douglas Emmett, Inc. (the “Company”) that he would not stand for re-election and will retire as a director of the Company.” 8-K

  • Trump Media & Technology Group (DJT) · Apr 10, 2026

    “On April 6, 2026, Eric Swider notified Trump Media & Technology Group Corp. (the “Company”) of his resignation from its Board of Directors (the “Board”), effective immediately.” 8-K

  • Tenet Health (THC) · Apr 10, 2026

    “On April 9, 2026 , Tenet Healthcare Corporation (the “Company”) and Paola Arbour entered into a Retirement Transition Agreement and General Release (the “Agreement”) that provides that Ms. Arbour will retire from her role as Executive Vice President and Chief Information Officer effective December 31, 2026, but will remain employed on a part-time basis in a non-executive role through April 1, 2028 to provide…” 8-K

  • Exicure (XCUR) · Apr 10, 2026

    “On April 8, 2026, the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) appointed Yoontae Han to serve as a director of the Company, effective as of April 8, 2026, until a successor has been duly elected and qualified or until his earlier death, resignation or removal, as a director of the Company.” 8-K

  • Kalaris Therapeutics (KLRS) · Apr 10, 2026

    “On April 8, 2026, Matthew Gall notified Kalaris Therapeutics, Inc. (the “Company”) of his decision to resign as the Chief Financial Officer of the Company, effective April 14, 2026 (the “Separation Date”).” 8-K

  • Intest (INTT) · Apr 10, 2026

    “On April 6, 2026, Gerald J. Maginnis, a Director on the Board of Directors (the “Board”) of InTest Corporation (the “Company”), Chairman of the Audit Committee of the Board and member of the Compensation Committee and Nominating and Corporate Governance Committee of the Board notified the Company of his intention not to stand for re-election to the Board at the Company’s 2026 annual meeting of shareholders (the…” 8-K

  • Orion S.A. (OEC) · Apr 10, 2026

    “Departure of Director As disclosed in the preliminary proxy statement for the 2026 annual general meeting of shareholders (the “Annual Meeting”) of Orion S.A. (the “Company”) filed with the SEC on April 10, 2026, Mr. Michel Wurth announced on April 6, 2026 his decision to not stand for re-election to the Board of Directors at the Annual Meeting due to increased responsibilities with other endeavours.” 8-K

The company's own words, from the opening sentence of its Form 8-K (Item 5.02).

5% stakes filed (Schedules 13D and 13G)

Largest federal contract awards

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Goldman Sachs free$9.99 a month, cancel anytime